Literature DB >> 27590586

Downregulation of IGF-1 receptor occurs after hepatic linage commitment during hepatocyte differentiation from human embryonic stem cells.

Ahmed Waraky1, Eiman Aleem2, Olle Larsson3.   

Abstract

The insulin-like growth factor 1 receptor (IGF-1R) has been suggested to be involved in hepatocyte differentiation. Human hepatocyte cancer cells and stem cells are known to express IGF-1R whereas normal hepatocytes do not. In the present study we optimized a differentiation protocol and verified the different stages by established markers. The expression levels of IGF-1R and major downstream signaling proteins during differentiation from human embryonic stem cells (hESC) to mature hepatocytes were investigated. We could only demonstrate a minor decrease in IGF-1R expression during endodermal differentiation compared to hESC, but declined substantially (>50%) after hepatic lineage commitment during the hepatocyte specification and maturation stages. This downregulation was paralleled by an upregulation of ERK 1/2, AKT and insulin substrate-1. Neither inhibition nor activation of IGF-1R had any essential effect on endoderm differentiation of human embryonic stem cells. Therefore, our data suggest that IGF-1R downregulation may have a regulatory impact after initiation of hepatic lineage commitment.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differentiation; Hepatocyte; IGF-1R

Mesh:

Substances:

Year:  2016        PMID: 27590586     DOI: 10.1016/j.bbrc.2016.08.157

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage.

Authors:  Ahmed Waraky; Yingbo Lin; Dudi Warsito; Felix Haglund; Eiman Aleem; Olle Larsson
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

Review 2.  Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease.

Authors:  Laura E Dichtel; Jose Cordoba-Chacon; Rhonda D Kineman
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

Review 3.  Towards Understanding the Direct and Indirect Actions of Growth Hormone in Controlling Hepatocyte Carbohydrate and Lipid Metabolism.

Authors:  Mari C Vázquez-Borrego; Mercedes Del Rio-Moreno; Rhonda D Kineman
Journal:  Cells       Date:  2021-09-24       Impact factor: 6.600

4.  Sheep recombinant IGF-1 promotes organ-specific growth in fetal sheep.

Authors:  J Stremming; A White; A Donthi; D G Batt; B Hetrick; E I Chang; S R Wesolowski; M B Seefeldt; C E McCurdy; P J Rozance; L D Brown
Journal:  Front Physiol       Date:  2022-08-25       Impact factor: 4.755

Review 5.  Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine.

Authors:  Syuan-Ling Lin; Chih-Yang Lin; Wei Lee; Chiao-Fang Teng; Woei-Cherng Shyu; Long-Bin Jeng
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

6.  GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner.

Authors:  Andre Sarmento-Cabral; Mercedes Del Rio-Moreno; Mari C Vazquez-Borrego; Mariyah Mahmood; Elena Gutierrez-Casado; Natalie Pelke; Grace Guzman; Papasani V Subbaiah; Jose Cordoba-Chacon; Shoshana Yakar; Rhonda D Kineman
Journal:  J Endocrinol       Date:  2021-01       Impact factor: 4.286

7.  Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.

Authors:  Takara L Stanley; Lindsay T Fourman; Isabel Zheng; Colin M McClure; Meghan N Feldpausch; Martin Torriani; Kathleen E Corey; Raymond T Chung; Hang Lee; David E Kleiner; Colleen M Hadigan; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.